CONCORD MEDICAL - SPON ADR

CCMNYSE

🏆 #4074 by market capEarnings Sep 25US Equity

$5.18▲ $1.00 (+19.35%)

🌙 After hours$5.00▼ 3.47%Regular close · extended-hours price shown

1h—

24h▲ 19.4%

7d—

14d—

30d—

1y—

🏦Market Cap

$675M

Small Cap

📈Revenue Growth (YoY)

+40.1%

High Growth

📊Gross Margin

11.6%

Thin

💵FCF Margin

208.5%

Strong

⚖️P/S Ratio

0.5x

Cheap

Otter Score

Fair

No chart data available for CCM.

Trading Snapshot

Day Range: $5.10 – $5.26
52-Week Range: —
Volume: $2.81B
Avg Volume: $1.90B
Shares Outstanding: 130.3M
Next Earnings: Sep 18, 2026

Fundamentals Snapshot

Annual Revenue: $461M
Last Q Revenue: $255M
P/E Ratio: —
P/S Ratio: 0.5x
EPS (TTM): —
Dividend Yield: —

Why Investors Own CCM

✓High-growth profile — revenue up +17.7% YoY with expanding US Equity exposure.
✓Healthy economics — 51% gross margin and 13% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$461M▲ +17.2% YoY

Gross Margin (TTM)

51.1%▲ +2.9% YoY

Operating Income (TTM)

$121M▲ +17.2% YoY

Free Cash Flow (TTM)

$60M▲ +17.2% YoY

About CONCORD MEDICAL - SPON ADR

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.

🦦